Navigation Links
People With Chronic Conditions Experience Additional Benefits of Cost Savings by Wearing a Medical ID
Date:9/25/2007

s everyday lifestyle. The medical IDs are available with various styles of bracelets, necklaces, watches and sportbands, in gold, gold-filled, sterling silver, stainless steel, titanium and nylon. Each ID is custom fitted and personalized with complimentary engraving. Candidates for a medical ID include anyone living with chronic or rare medical conditions such as diabetes, asthma, heart conditions, stroke risk or memory impairment; persons with allergies such as food, drug or insect; or those taking multiple medications or blood thinners.

American Medical ID also provides a free Online Medical Registry, where participants can maintain an online personal health file of their medical conditions, emergency contact information, prescriptions, over-the-counter medications and personal and medical files such as living wills, donor cards, EKGs and CTs. This file can be accessed anytime through a secure online connection or a 24-hour emergency telephone line. The program also provides 24/7 unlimited access to a registered nurse for emergencies or ongoing health questions.

For more information about American Medical ID, visit http://www.IdentifyYourself.com.


'/>"/>
SOURCE American Medical ID
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Bad News for Short People
2. New hope on the Horizon for People Wishing to Quit Smoking
3. Antioxidants protect health tissue in people undergoing radiation therapy.
4. Skinny people need to exercise too
5. People who fight wars may be at high risk of cardiovascular disease
6. People suffering from Alzheimer’s: can they take decisions about their treatment
7. Democracy Not To Be Forced On People
8. Prescription Drug - Helps People Stop Smoking
9. Hormone treatment helps obese people slim down
10. Safe for people with asthma
11. More People Seeking Treatment for Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...to be the first malarial outbreak in 40 years, hea...have come down with malaria.// No fresh cases of ...he major resort locations are free of the infectio...s one of the world‘s deadliest diseases, killing a...
...risk factor for cardiovascular diseases.A potbelly...re even if the rest of the body is skinny as a bea...ctor of risk is the relationship of waist size to ...atio predicts an increased risk of heart attack. T...
...ts plea to doctors over prescription of cheaper dr...ions in the coming year if GPs// prescribed cheape...s (PCTs) can prescribe generic versions of the dru...e two of five ‘statin’ drugs that are approved for...
... potential beneficial effects of TNFa inhibition i...anti-TNFa treatment in aging," appears in the Janu...his study shows hope for significantly reducing va...TNFa, which has been linked to blood vessel dysfun...
Other Medicine News:Health News:Pot Belly Is A Better Risk Predictor Of Heart Attack Than BMI 2Health News:Effects Of Age-related Vascular Diseases Can Be Reduced By Inactivating TNFa 2
(Date:7/22/2008)...lidated by Columbia University Medical Center Base...RNA Technology, The Test Differentiates Squamous...CLC), Classifying Squamous-Cell Carcinoma of the L...ificity of 90 Percent,This is the First CLIA Appro... as Biomarkers for Accurate Diagnosis of Lun...
(Date:7/22/2008)... France, July 22 /- NicOx S...uccessfully completed the,enrollment of 417 osteoa...n,in two clinical pharmacology studies in the Unit...ines. These trials are designed to assess the,bloo...o ibuprofen and,naproxen, using the Ambulatory Blo...
(Date:7/22/2008)...sts That Ekkyo,s New Approach of LASH (Laser Assis... Healing Physiology, MARSEILLES, France, July 22 ...Technology) a photomedicine company, which develop... prevention and reduction, announced today,the pub...ery and Medicine*,reporting the results of a pilot...
(Date:7/21/2008)... /- Ari Kiev, M.D., president of SPRI...e upcoming conference Wall,Street Unplugged: The T...to,Wall Street. The conference will be held on Wed...fth Avenue in New York. The event is targeted to C... science companies to gain,better insight into Wal...
Breaking Medicine Technology:First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3Health Fitness Completes Share Repurchase Plan 20254 1Health Fitness Completes Share Repurchase Plan 20254 2Current vitamin D recommendations fraction of safe perhaps essential levels for children 20248 1Current vitamin D recommendations fraction of safe perhaps essential levels for children 20248 2ev3 Inc to Present at the Goldman Sachs Twenty Ninth Annual Global Healthcare Conference 20245 1Pacific Biosciences Acquires Single Molecule Sequencing Technology from LI COR Biosciences 5622 1Pacific Biosciences Acquires Single Molecule Sequencing Technology from LI COR Biosciences 5622 2Pacific Biosciences Acquires Single Molecule Sequencing Technology from LI COR Biosciences 5622 3
... Disease Week -, CAMBRIDGE, Mass., May 21, 2007 /P...ation of data from a Phase 2 study in which,linacl...el function,in patients with constipation- predomi...also showed linaclotide was well tolerated with,a ...first-in-class,compound currently being developed ...
...ts from phase III,clinical trials and further huma...Congress of the European Academy of,Dermatology an...fficacy and safety profile of alitretinoin as a po...h severe refractory chronic,hand eczema. , Current...c Hand,Eczema (CHE) refractory or unresponsive to ...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5
...ue processor features superior user comfort with s...closed, stand-alone system for processing of up to...ocessor combines proven technology with an innovat... use,yet powerful software. Many routine user oper...
...mily are semi-enclosed tissue processors. The Leic...nology with modern and functionally enhanced desig...or tissues at all stages of the processing run, ro...mechanics in conjunction with a modern user interf...
...w tissue infiltration instrument, which combines w...erly way. The robust caroussel design is proven an... instrument includes either 10 reagent and 2 paraf...ers. Up to 10 different programs can be stored all...
...with automatic fine/trim- feed system, specimen re...ecision cross roller bearings. For sectioning para...in biological, botany, and materials science. Spec...Performance, ergonomy and design of this sliding m...
Medicine Products: